---
$id: https://graph.org.ai/products/commodity/51161554
$type: Product
source: UNSPSC
code: "51161554"
title: "Ritolukast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ritolukast

**UNSPSC Code**: 51161554
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C17H13F3N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0E8R4GDE2Q, chemically known as 1,1,1-trifluoro-alpha-2-quinolylmethanesulfon-m-anisidide but generally known as ritolukast, which bears US NIH Compound Identifier 60539. European Medicines Agency schedules Ritolukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10341MIG. The term RITOLUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). Most nations schedule ritolukast under HS 29350090 and SITC 51580. As of Q4 2014, RITOLUKAST remains the US FDA Preferred Term for this commodity. Ritolukast bears US NLM identifiers UMLS ID C2347965 and NCI Concept Code C74129. SMILES: S(=O)(=O)(NC1CC(OCC2NC3C(CC2)CCCC3)CCC1)C(F)(F)F.

